The outbreak of SARS-CoV-2 pneumonia calls for viral vaccines
W Shang, Y Yang, Y Rao, X Rao - npj Vaccines, 2020 - nature.com
The outbreak of 2019-novel coronavirus disease (COVID-19) that is caused by SARS-CoV-2
has spread rapidly in China, and has developed to be a Public Health Emergency of …
has spread rapidly in China, and has developed to be a Public Health Emergency of …
[HTML][HTML] SARS-CoV-2 vaccines: status report
F Amanat, F Krammer - Immunity, 2020 - cell.com
SARS-CoV-2, the causal agent of COVID-19, first emerged in late 2019 in China. It has since
infected more than 870,000 individuals and caused more than 43,000 deaths globally. Here …
infected more than 870,000 individuals and caused more than 43,000 deaths globally. Here …
A Review of the Progress and Challenges of Developing a Vaccine for COVID-19
A novel coronavirus, which has been designated as severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), was first detected in December 2019 in Wuhan China and …
coronavirus 2 (SARS-CoV-2), was first detected in December 2019 in Wuhan China and …
[HTML][HTML] Targets and strategies for vaccine development against SARS-CoV-2
JA Malik, AH Mulla, T Farooqi, FH Pottoo… - Biomedicine & …, 2021 - Elsevier
Abstract The SARS-CoV-2, previously called a novel coronavirus, that broke out in the
Wuhan city of China caused a significant number of morbidity and mortality in the world. It is …
Wuhan city of China caused a significant number of morbidity and mortality in the world. It is …
COVID-19: coronavirus vaccine development updates
J Zhao, S Zhao, J Ou, J Zhang, W Lan, W Guan… - Frontiers in …, 2020 - frontiersin.org
Coronavirus Disease 2019 (COVID-19) is caused by Severe Acute Respiratory Syndrome
Coronavirus 2 (SARS-CoV-2), a newly emerged coronavirus, and has been pandemic since …
Coronavirus 2 (SARS-CoV-2), a newly emerged coronavirus, and has been pandemic since …
Vaccines for COVID-19: a systematic review of immunogenicity, current development, and future prospects
Z Zhang, Q Shen, H Chang - Frontiers in immunology, 2022 - frontiersin.org
The persistent coronavirus disease 2019 (COVID-19), characterized by severe respiratory
syndrome, is caused by coronavirus 2 (SARS-CoV-2), and it poses a major threat to public …
syndrome, is caused by coronavirus 2 (SARS-CoV-2), and it poses a major threat to public …
Potential therapeutic targets and vaccine development for SARS-CoV-2/COVID-19 pandemic management: a review on the recent update
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a highly pathogenic
novel virus that has caused a massive pandemic called coronavirus disease 2019 (COVID …
novel virus that has caused a massive pandemic called coronavirus disease 2019 (COVID …
The emergence of new strains of SARS-CoV-2. What does it mean for COVID-19 vaccines?
MK Hossain, M Hassanzadeganroudsari… - Expert review of …, 2021 - Taylor & Francis
A novel strain of coronavirus, SARS-CoV-2, the causative agent of coronavirus disease
(COVID-19) was first associated with severe acute respiratory disease in late 2019 and has …
(COVID-19) was first associated with severe acute respiratory disease in late 2019 and has …
Landscape and progress of global COVID-19 vaccine development
HY Huang, SH Wang, Y Tang, W Sheng… - Human Vaccines & …, 2021 - Taylor & Francis
The emergence of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has
affected billions of lives globally, and the world hopes to end this epidemic by effective …
affected billions of lives globally, and the world hopes to end this epidemic by effective …
Better strategies for coronavirus (COVID-19) vaccination
N Tzenios, M Chahine, M Tazanios - … of the Medical Academy and other …, 2023 - sjmas.com
The first case of COVID-19 a coronavirus disease, was reported in December 2019 in
Wuhan, China, and spread globally. Severe acute respiratory syndrome coronavirus 2 …
Wuhan, China, and spread globally. Severe acute respiratory syndrome coronavirus 2 …